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Topological (2D) Fuzzy Pharmacophore Triplets (2D-
FPT), using the number of interposed bonds to measure
separation between the atoms representing pharmacoph-
ore types, were employed to establish and validate Quan-
titative Structure-Activity Relationships (QSAR). Thirteen
data sets for which state-of-the-art QSAR models were
reported in literature were revisited in order to benchmark
2D-FPT biological activity-explanatory propensities. Lin-
ear and non-linear QSAR models were constructed for
each compound series (following the original author's
splitting into training/validation subsets) with three dif-
ferent 2D-FPT versions, using the Genetic Algorithm
(GA)-based Stochastic QSAR Sampler (SQS) to pick rele-
vant triplets and fit their coefficients.
Beyond the benchmarking studies, in which 2D-FPT mod-
els validated better than, or as well as the best among
reported literature equations, including 3D overlay-
dependent computer-intensive techniques, this work is
concerned with the in-depth analysis of the ‘topological
pharmacophores’ defined by the sets of triplets entering
the models. Do these really pinpoint the actual functional
groups involved in the non-covalent binding of the ligand
to the active site? May the use of topological distances
replace the actual 3D distances in the bioactive con-
former? On hand of an in-depth study of thrombin inhib-
itor models, it was shown that triplets entering a model
are often at risk of having been selected because of corre-
lation artefacts caused by the low diversity of the training/
validation set. The initial set of models were, robust vali-
dation scores notwithstanding, either unable to recognize
any of the structurally different actives they were chal-
lenged with, or else tended to predict any molecule out-
side the training set as active. Fortunately, while CoMFA
restricts training molecule diversity in order to get mean-
ingful overlays, 2D-FPT models can (and should!) be
trained on sets of compounds of arbitrary diversity – addi-
tion of assumed inactive random compounds to the struc-
turally homogeneous thrombin inhibitor series produced
models that successfully extrapolate to molecules of dif-
ferent topology.
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